- Home
- SKT vs KRYS Comparison
SKT vs KRYS Comparison
Compare SKT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKT
- KRYS
- Stock Information
- Founded
- SKT 1981
- KRYS 2015
- Country
- SKT United States
- KRYS United States
- Employees
- SKT N/A
- KRYS N/A
- Industry
- SKT Real Estate Investment Trusts
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SKT Real Estate
- KRYS Health Care
- Exchange
- SKT Nasdaq
- KRYS Nasdaq
- Market Cap
- SKT 3.3B
- KRYS 3.6B
- IPO Year
- SKT 1993
- KRYS 2017
- Fundamental
- Price
- SKT $30.03
- KRYS $133.05
- Analyst Decision
- SKT Buy
- KRYS Strong Buy
- Analyst Count
- SKT 8
- KRYS 8
- Target Price
- SKT $37.00
- KRYS $211.13
- AVG Volume (30 Days)
- SKT 1.0M
- KRYS 348.9K
- Earning Date
- SKT 08-04-2025
- KRYS 08-04-2025
- Dividend Yield
- SKT 3.90%
- KRYS N/A
- EPS Growth
- SKT N/A
- KRYS 109.01
- EPS
- SKT 0.85
- KRYS 4.16
- Revenue
- SKT $549,227,000.00
- KRYS $333,448,000.00
- Revenue This Year
- SKT $0.92
- KRYS $44.05
- Revenue Next Year
- SKT $4.18
- KRYS $46.15
- P/E Ratio
- SKT $35.38
- KRYS $31.88
- Revenue Growth
- SKT 12.63
- KRYS 247.53
- 52 Week Low
- SKT $25.94
- KRYS $122.80
- 52 Week High
- SKT $37.57
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- SKT 49.04
- KRYS 44.16
- Support Level
- SKT $29.62
- KRYS $127.99
- Resistance Level
- SKT $30.25
- KRYS $143.20
- Average True Range (ATR)
- SKT 0.60
- KRYS 4.23
- MACD
- SKT 0.06
- KRYS 1.01
- Stochastic Oscillator
- SKT 58.01
- KRYS 44.48
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.